BeyondSpring Inc


Prices are adjusted according to historical splits.

BeyondSpring Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$48.30 million
Book Value:
Revenue TTM:
$1.35 million
Operating Margin TTM:
Gross Profit TTM:
$1.35 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

BeyondSpring Inc had its IPO on 2017-03-09 under the ticker symbol BYSI.

The company operates in the Healthcare sector and Biotechnology industry. BeyondSpring Inc has a staff strength of 103 employees.

Stock update

Shares of BeyondSpring Inc opened at $1.25 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $1.19 - $1.28, and closed at $1.24.

This is a -0.8% slip from the previous day's closing price.

A total volume of 88,400 shares were traded at the close of the day’s session.

In the last one week, shares of BeyondSpring Inc have slipped by -23.46%.

BeyondSpring Inc's Key Ratios

BeyondSpring Inc has a market cap of $48.30 million, indicating a price to book ratio of 1.6777 and a price to sales ratio of 62.2401.

In the last 12-months BeyondSpring Inc’s revenue was $1.35 million with a gross profit of $1.35 million and an EBITDA of $-49594500. The EBITDA ratio measures BeyondSpring Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BeyondSpring Inc’s operating margin was -3674.98% while its return on assets stood at -42.42% with a return of equity of -146.8%.

In Q4, BeyondSpring Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

BeyondSpring Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-1.21 per share while it has a forward price to earnings multiple of 10.5374 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BeyondSpring Inc’s profitability.

BeyondSpring Inc stock is trading at a EV to sales ratio of 5.269 and a EV to EBITDA ratio of 0.3725. Its price to sales ratio in the trailing 12-months stood at 62.2401.

BeyondSpring Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$63.77 million
Total Liabilities
$11.11 million
Operating Cash Flow
Capital Expenditure
$2.81 million
Dividend Payout Ratio

BeyondSpring Inc ended 2023 with $63.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $63.77 million while shareholder equity stood at $8.11 million.

BeyondSpring Inc ended 2023 with $0 in deferred long-term liabilities, $11.11 million in other current liabilities, in common stock, $-360486000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $30.74 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

BeyondSpring Inc’s total current assets stands at $55.73 million while long-term investments were $0 and short-term investments were $21.20 million. Its net receivables were $0 compared to accounts payable of $1.16 million and inventory worth $0.

In 2023, BeyondSpring Inc's operating cash flow was $-4729000.00 while its capital expenditure stood at $2.81 million.

Comparatively, BeyondSpring Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

BeyondSpring Inc stock is currently trading at $1.24 per share. It touched a 52-week high of $3.45 and a 52-week low of $3.45. Analysts tracking the stock have a 12-month average target price of $1.

Its 50-day moving average was $2.1 and 200-day moving average was $1.46 The short ratio stood at 9.42 indicating a short percent outstanding of 0%.

Around 5128.5% of the company’s stock are held by insiders while 1549.3% are held by institutions.

Frequently Asked Questions About BeyondSpring Inc

The stock symbol (also called stock or share ticker) of BeyondSpring Inc is BYSI

The IPO of BeyondSpring Inc took place on 2017-03-09

Similar Industry Stocks (Biotechnology)

Last Price
Equinor ASA (STOHF)

Most Active

Last Price

Top Gainers

Last Price

Top Losers

Last Price


BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company’s lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.


28 Liberty Street, New York, NY, United States, 10005